The innovative research conducted by our physicians and faculty has paved the way for more effective methods of prevention, diagnosis, and treatment of gastrointestinal diseases.
In our mission to create knowledge through research, the Division of Gastroenterology and Hepatology continues to conduct cutting-edge investigations of the molecular, cellular, and physiological conditions of healthy and diseased states of the gastrointestinal tract, liver, and pancreas. The central piece of the Division's research endeavor is the NIH-funded University of Michigan Center for Gastrointestinal Research, which encompasses three thematic areas of research:
- neurobiology of appetite control and visceral pain
- molecular and cellular mechanisms of inflammation
- cell growth, differentiation, and programmed cell death
Joel Rubenstein, MD, MSc and team examine the relationship between proton pump inhibitors, endoscopy, esophageal conditions, and psychological distress for patients with GERD.
Anna Lok, MD compares rates of cirrhosis, cardiovascular disease, and metabolic abnormalities between patients with fatty liver disease who are of normal weight and overweight or obese.